Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0) - Draft for stakeholder discussion and call for action
ALTEX
.
2020;37(3):490-492.
doi: 10.14573/altex.2007091.
Authors
David Pamies
1
,
Marcel Leist
2
3
,
Sandra Coecke
4
,
Gerard Bowe
4
,
Dave Allen
5
,
Gerhard Gstraunthaler
6
,
Anna Bal-Price
4
,
Francesca Pistollato
4
,
Rob DeVries
7
8
,
Thomas Hartung
2
9
,
Glyn Stacey
10
11
12
Affiliations
1
Department of Biomedical Science, University of Lausanne, Lausanne, Vaud, Switzerland.
2
Center for Alternatives to Animal Testing (CAAT) Europe, University of Konstanz, Konstanz, Germany.
3
In vitro Toxicology and Biomedicine, Dept inaugurated by the Doerenkamp-Zbinden Foundation, University of Konstanz, Konstanz, Germany.
4
European Commission, Joint Research Centre (JRC), Ispra, Italy.
5
Integrated Laboratory Systems, LLC., Morrisville, NC, USA.
6
Medical University Innsbruck, Department of Physiology, Innsbruck, Austria.
7
Evidence-based Toxicology Collaboration, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
8
SYRCLE, Department for Health Evidence, Radboud Institute for Health Sciences, Radboud UMC, Nijmegen, The Netherlands.
9
Center for Alternatives to Animal Testing (CAAT), Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, USA.
10
International Stem Cell Banking Initiative, Barley, Herts, UK.
11
National Stem Cell Resource Centre, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
12
Innovation Academy for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.
PMID:
32686838
DOI:
10.14573/altex.2007091
No abstract available
Publication types
Letter
MeSH terms
Animal Testing Alternatives*
Animals
Cell Culture Techniques / standards*
Guidelines as Topic
Humans
Stakeholder Participation*
Tissue Culture Techniques / standards*